Novo Nordisk | NVO - Ebit

Stock Price
47.20
Daily Change
-3.05 -6.07%
Monthly
-14.43%
Yearly
-45.00%
Q1 Forecast
56.42

Novo Nordisk reported DKK5.18B in EBIT for its fiscal quarter ending in June of 2025.





Ebit Change Date
ANI Pharmaceuticals USD 22.83M 7.66M Sep/2025
Aurora Cannabis CAD -44.75M 27.14M Sep/2025
Bausch Health Companies USD 717M 112M Sep/2025
Bristol-Myers Squibb USD 4.04B 1.78B Sep/2025
Canopy Growth CAD -14.3M 17.19M Sep/2025
Corcept Therapeutics USD 10.22M 16.46M Sep/2025
Drreddys Laboratories INR 16.37B 3.5B Dec/2025
Eli Lilly USD 7.41B 391.2M Sep/2025
GlaxoSmithKline GBP 2.79B 716M Sep/2025
Merck USD 6.24B 1.32B Dec/2025
Novartis USD -9.19B 13.87B Jun/2025
Novo Nordisk DKK 32.38B 1.7B Dec/2025
Novo Nordisk DKK 5.18B 37.04B Jun/2025
Pacira USD 13.15M 2.92M Sep/2025
Perrigo USD 93.4M 37.8M Sep/2025
Prestige Brands USD 79.67M 7.91M Sep/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Supernus Pharmaceuticals USD -60.18M 72.33M Sep/2025
Zoetis USD 975M 40M Sep/2025